deCODE Receives Trading Suspension and Delisting Notice from Nasdaq
News Jan 05, 2010
deCODE genetics, Inc. has announced that it has received notice from the Nasdaq Stock Market that the company’s common stock will be suspended from the Nasdaq Stock Market as of the open of business on January 6, 2010 and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove deCODE’s common stock from listing on Nasdaq.
Following this action, it is possible that deCODE’s common stock will be traded on the inter-dealer quotation service known as the “Pink Sheets.” However this is not certain, as it would require a market maker to quote the stock, and there is no guarantee that any market maker will do so.
In addition, so long as deCODE is not current in its reporting obligations under the Securities Exchange Act of 1934, any such quotation will be subject to additional restrictions.
Researchers have created a portable and fast-acting test that can distinguish Ebola infections from other fever-causing infectious diseases such as Lassa fever and malaria in around 30 minutes. Although further testing is required, this could be useful during febrile disease outbreaks.READ MORE